Skip to main content
Clinical Trials/NCT03537222
NCT03537222TerminatedNot Applicable

Validation of the Myeloma Patient Outcome Scale (MyPOS) Assessing the Quality of Life in Patients With Multiple Myeloma in the German Speaking Part of Switzerland

Zurich University of Applied Sciences3 sites in 1 country58 target enrollmentStarted: October 10, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
58
Locations
3
Primary Endpoint
Psychometric properties of the culturally-adapted Swiss-German Myeloma Patient Outcome Scale (MyPOS)

Study Overview

Brief Summary

In this study, the Myeloma Patient Outcome Scale (MyPOS) will be translated from English to German. This translated version will be quantitatively and qualitatively validated with patients with multiple myeloma.

Detailed Description

Patients with multiple myeloma (N=10) will be interviewed in the qualitative phase about their comprehension of the translated MyPOS. The questionnaire will be revised according to the results of the interviews. This culturally adapted Swiss-German MyPOS will be assessed in the quantitative phase for its' psychometric properties with 200 patients with multiple myeloma.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •informed consent as documented by signature
  • •confirmed histological diagnosis of multiple myeloma,
  • •age ≥ 18 years,
  • •mental capacity to give written informed consent

Exclusion Criteria

  • •inability to communicate in German
  • •participation in another clinical study
  • •more than one cancer diagnosis
  • •mental illness (i.e. psychiatric diagnosis)

Outcomes

Primary Outcomes

Psychometric properties of the culturally-adapted Swiss-German Myeloma Patient Outcome Scale (MyPOS)

Time Frame: upon enrollment

The primary outcome will be the scores on each item of the culturally-adapted Swiss-German MyPOS. Items are scored on a five-point Likert scale. For the analysis, the three subscales "Symptoms" (range: 0-52), "Emotions" (range:0-68) and "Healthcare Support" (range: 0-12) are assessed as well as the MyPOS total score (range: 0-132 ) by summing up the item scores ranging from 0-4. Higher scores reflect worse quality of life. The scores will be used to evaluate the psychometric properties of the culturally-adapted Swiss-German MyPOS: * Structural validity, * Internal consistency, * Construct validity, * Convergent and divergent validity.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Zurich University of Applied Sciences
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Dr. med. Julia Dratva

Head of health sciences research unit

Zurich University of Applied Sciences

Study Sites (3)

Loading locations...

Similar Trials